Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 August 2018 Photo Xolisa Mnukwa
Haemophilia workshop the first of its kind at UFS
The UFS Department of Haematology and Cell Biology is producing quality medical graduates, addressing the high demand for trained graduates. Dr Anneke van Marle, Haematologist in the department, presented a lecture to final-year medical students on muscle and soft-tissue bleeding in haemophilia.

The Medical and Scientific Advisory Council (MASAC) of the South African Haemophilia Foundation (SAHF) has identified a need for more in-depth training of junior doctors on the basic aspects of the bleeding disorder haemophilia. 

Addressing this need in the sector, the Department of Haematology and Cell Biology at the University of the Free State (UFS) recently hosted a training workshop specifically targeting final-year medical students before they enter practice.

The Novo Nordisk Haemophilia Foundation is sponsoring this countrywide haemophilia training.

According to Jaco Joubert, Senior Lecturer and Pathologist in the Department of Haematology and Cell Biology, the department is very active in the field of haemophilia treatment, research and training, with representation on the Executive Committee of the Medical and Scientific Advisory Council of the South African Haemophilia Foundation.

Function with confidence

“The UFS Department of Haematology and Cell Biology has taken a proactive approach, by being the first department in South Africa to offer this training course to final-year medical students at the UFS; an investment in the future. The department runs the Bloemfontein Haemophilia Treatment Centre – which is the main haemophilia treatment and referral centre for patients from the Free State and Northern Cape. It is therefore ideally positioned to offer such training to students,” said Joubert.

Proactive role

The training workshop empowered and equipped students with more extensive knowledge on the practical aspects of managing patients with haemophilia; the various treatment products currently available in South Africa and laboratory diagnostic approaches in complicated cases. “This will enable students to function with more confidence during their internship and community service years,” said Joubert. 

He believes a training workshop of this calibre showcases the proactive role the department and the university is taking in the advancement of haemophilia training in South Africa.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept